Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
HPG-1860 by Hepagene Therapeutics Shanghai for Primary Biliary Cholangitis (Primary Biliary Cirrhosis): Likelihood of Approval
HPG-1860 is under clinical development by Hepagene Therapeutics Shanghai and currently in Phase I for Primary Biliary Cholangitis (Primary Biliary...